Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789317-22-000004
Filing Date
2022-07-19
Accepted
2022-07-19 16:42:33
Documents
1
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165826334018650.html 4  
1 FORM 4 wf-form4_165826334018650.xml 4 3932
  Complete submission text file 0001789317-22-000004.txt   5526
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIELA BIO, INC., ONE MEDIMMUNE WAY FIRST FLOOR, AREA TWO GAITHERSBURG MD 20878
Business Address
Drappa Jorn (Reporting) CIK: 0001789317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 221091969